4.6 Article

Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease

期刊

ACTA NEUROPATHOLOGICA
卷 143, 期 1, 页码 15-31

出版社

SPRINGER
DOI: 10.1007/s00401-021-02383-3

关键词

Limbic-predominant age-related TDP-43 encephalopathy; TDP-43 proteinopathy; Lewy body disease; TMEM106B; GRN

资金

  1. Japan Society for the Promotion of Science (JSPS) [201870008, 201860169]
  2. Uehara Memorial Foundation
  3. Alzheimer's Association Research Fellowship [AARF-D-619473]
  4. RAPID Program in Dementia [AARF-D-619473-RAPID]
  5. US National Institute of Aging (NIA) of National Institutes of Health (NIH) [K23-NS11416-01A1, P30 AG010124, T32-AG000255, P30 AG072979, P01 AG066597, U19 AG062418, P50 NS053488]
  6. US National Institute of Neurological Disorders and Stroke (NINDS) of National Institutes of Health (NIH) [K23-NS11416-01A1, P30 AG010124, T32-AG000255, P30 AG072979, P01 AG066597, U19 AG062418, P50 NS053488]
  7. LBDA, Penn IOA

向作者/读者索取更多资源

Limbic-predominant age-related TDP-43 encephalopathy (LATE) is characterized by the accumulation of TAR-DNA-binding protein 43 (TDP-43) aggregates in older adults and coexists with Lewy body disease (LBD) and Alzheimer's disease (AD). Pathological and genetic characteristics of LATE in LBD (LATE-LBD) differ from LATE-AD, with associations to patient profiles and cognitive impairment. The distribution of LATE neuropathological changes and genetic risk factors also vary between LATE-LBD and LATE-AD.
Limbic-predominant age-related TDP-43 encephalopathy (LATE) is characterized by the accumulation of TAR-DNA-binding protein 43 (TDP-43) aggregates in older adults. LATE coexists with Lewy body disease (LBD) as well as other neuropathological changes including Alzheimer's disease (AD). We aimed to identify the pathological, clinical, and genetic characteristics of LATE in LBD (LATE-LBD) by comparing it with LATE in AD (LATE-AD), LATE with mixed pathology of LBD and AD (LATE-LBD + AD), and LATE alone (Pure LATE). We analyzed four cohorts of autopsy-confirmed LBD (n = 313), AD (n = 282), LBD + AD (n = 355), and aging (n = 111). We assessed the association of LATE with patient profiles including LBD subtype and AD neuropathologic change (ADNC). We studied the morphological and distributional differences between LATE-LBD and LATE-AD. By frequency analysis, we staged LATE-LBD and examined the association with cognitive impairment and genetic risk factors. Demographic analysis showed LATE associated with age in all four cohorts and the frequency of LATE was the highest in LBD + AD followed by AD, LBD, and Aging. LBD subtype and ADNC associated with LATE in LBD or AD but not in LBD + AD. Pathological analysis revealed that the hippocampal distribution of LATE was different between LATE-LBD and LATE-AD: neuronal cytoplasmic inclusions were more frequent in cornu ammonis 3 (CA3) in LATE-LBD compared to LATE-AD and abundant fine neurites composed of C-terminal truncated TDP-43 were found mainly in CA2 to subiculum in LATE-LBD, which were not as numerous in LATE-AD. Some of these fine neurites colocalized with phosphorylated alpha-synuclein. LATE-LBD staging showed LATE neuropathological changes spread in the dentate gyrus and brainstem earlier than in LATE-AD. The presence and prevalence of LATE in LBD associated with cognitive impairment independent of either LBD subtype or ADNC; LATE-LBD stage also associated with the genetic risk variants of TMEM106B rs1990622 and GRN rs5848. These data highlight clinicopathological and genetic features of LATE-LBD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据